Novel drug tackles uncontrolled hypertension caused by aldosterone dysregulation

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone dysregulation, often driven by obesity and primary aldosteronism, affects up to 30% of patients with hypertension, many of whom are undiagnosed or untreated.

…